Tirzepatide has a dual mechanism of action through the GLP-1 and GIP receptor agonist. Its dual action makes it distinct from medications like semaglutide, which primarily target the GLP-1 receptor alone.
Potential benefits of tirzepatide with dual receptor agonist action:
*Activation of the GIP receptor (Glucose Dependent Insulinotropic Polypeptide, also known as Gastric Inhibiting Polypeptide)
High Quality, Fast Turnaround GLP-1 Injections During the FDA Shortage
Compounded Semaglutide & Tirzepatide GLP 1s: How We Help Patients – Patient Video Instructions
Privacy Policy This website collects data anonymously to make your experience better. You may choose to opt-out of data sharing any time. Learn More.
The information contained in this website or provided through our blogs, e-mails, videos, programs, services or products is for educational purposes only and is not intended to substitute for professional medical advice, services, diagnosis or treatment. Full Disclaimer
Copyright © 2024 Town & Country Compounding | Privacy Policy | Disclaimer | Website by Monsoon Marketing